PPAR#947; and Its Ligands: Potential Antitumor Agents in the Digestive System

Publisher： Bentham Science Publishers

E-ISSN：  2212-3946|11|3|274-281

ISSN： 1574-888x

Source： Current Stem Cell Research & Therapy, Vol.11, Iss.3, 2016-03, pp. : 274-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 3, 2016-04 ,pp. : 274-281

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;) Ligands: Novel Pharmacological Agents in the Treatment of Ischemia Reperfusion Injury

By  

Current Molecular Medicine, Vol. 8, Iss. 6, 2008-01 ,pp. : 562-579

Bentham Science Publishers

Access to resources Recommend Favorite

The Antidiabetic PPAR&ggr; Ligands: An Update on Compounds in Development

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 2, Iss. 1, 2002-03 ,pp. : 33-47

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-#947 and Its Ligands in the Treatment of Tumors in the Nervous System

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 3, 2016-04 ,pp. : 208-215

Bentham Science Publishers

Access to resources Recommend Favorite

Role of PPAR-&ggr; Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 5, 2005-01 ,pp. : 377-386

Bentham Science Publishers

Access to resources Recommend Favorite